Logo image of AKE.PA

ARKEMA (AKE.PA) Stock Fundamental Analysis

EPA:AKE - Euronext Paris - Matif - FR0010313833 - Common Stock - Currency: EUR

65.35  -1.3 (-1.95%)

Fundamental Rating

5

Overall AKE gets a fundamental rating of 5 out of 10. We evaluated AKE against 66 industry peers in the Chemicals industry. Both the profitability and the financial health of AKE get a neutral evaluation. Nothing too spectacular is happening here. AKE is not valued too expensively and it also shows a decent growth rate. Finally AKE also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year AKE was profitable.
AKE had a positive operating cash flow in the past year.
In the past 5 years AKE has always been profitable.
AKE had a positive operating cash flow in each of the past 5 years.
AKE.PA Yearly Net Income VS EBIT VS OCF VS FCFAKE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of 2.22%, AKE is in the better half of the industry, outperforming 62.12% of the companies in the same industry.
The Return On Equity of AKE (4.49%) is better than 63.64% of its industry peers.
AKE has a better Return On Invested Capital (3.98%) than 63.64% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AKE is in line with the industry average of 6.30%.
Industry RankSector Rank
ROA 2.22%
ROE 4.49%
ROIC 3.98%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
AKE.PA Yearly ROA, ROE, ROICAKE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 3.54%, AKE is in the better half of the industry, outperforming 60.61% of the companies in the same industry.
In the last couple of years the Profit Margin of AKE has declined.
Looking at the Operating Margin, with a value of 7.52%, AKE is in the better half of the industry, outperforming 65.15% of the companies in the same industry.
In the last couple of years the Operating Margin of AKE has declined.
Looking at the Gross Margin, with a value of 20.32%, AKE is doing worse than 68.18% of the companies in the same industry.
AKE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.52%
PM (TTM) 3.54%
GM 20.32%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
AKE.PA Yearly Profit, Operating, Gross MarginsAKE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AKE is creating some value.
Compared to 1 year ago, AKE has more shares outstanding
The number of shares outstanding for AKE has been reduced compared to 5 years ago.
AKE has a worse debt/assets ratio than last year.
AKE.PA Yearly Shares OutstandingAKE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AKE.PA Yearly Total Debt VS Total AssetsAKE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 1.80, we must say that AKE is in the distress zone and has some risk of bankruptcy.
AKE's Altman-Z score of 1.80 is on the low side compared to the rest of the industry. AKE is outperformed by 60.61% of its industry peers.
AKE has a debt to FCF ratio of 12.65. This is a negative value and a sign of low solvency as AKE would need 12.65 years to pay back of all of its debts.
The Debt to FCF ratio of AKE (12.65) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.49 indicates that AKE is not too dependend on debt financing.
AKE has a Debt to Equity ratio of 0.49. This is comparable to the rest of the industry: AKE outperforms 48.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 12.65
Altman-Z 1.8
ROIC/WACC0.77
WACC5.15%
AKE.PA Yearly LT Debt VS Equity VS FCFAKE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

AKE has a Current Ratio of 2.01. This indicates that AKE is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of AKE (2.01) is better than 63.64% of its industry peers.
A Quick Ratio of 1.47 indicates that AKE should not have too much problems paying its short term obligations.
AKE has a better Quick ratio (1.47) than 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 1.47
AKE.PA Yearly Current Assets VS Current LiabilitesAKE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

4

3. Growth

3.1 Past

AKE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.91%.
The Earnings Per Share has been growing slightly by 0.10% on average over the past years.
The Revenue has been growing slightly by 0.32% in the past year.
Measured over the past years, AKE shows a small growth in Revenue. The Revenue has been growing by 1.78% on average per year.
EPS 1Y (TTM)-9.91%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-34.43%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-5.78%

3.2 Future

AKE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.55% yearly.
The Revenue is expected to grow by 4.13% on average over the next years.
EPS Next Y-2.71%
EPS Next 2Y5.68%
EPS Next 3Y6.35%
EPS Next 5Y8.55%
Revenue Next Year1.65%
Revenue Next 2Y2.89%
Revenue Next 3Y3.26%
Revenue Next 5Y4.13%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AKE.PA Yearly Revenue VS EstimatesAKE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B 10B
AKE.PA Yearly EPS VS EstimatesAKE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

AKE is valuated reasonably with a Price/Earnings ratio of 8.62.
95.45% of the companies in the same industry are more expensive than AKE, based on the Price/Earnings ratio.
AKE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.82.
AKE is valuated cheaply with a Price/Forward Earnings ratio of 7.13.
Based on the Price/Forward Earnings ratio, AKE is valued cheaply inside the industry as 95.45% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, AKE is valued rather cheaply.
Industry RankSector Rank
PE 8.62
Fwd PE 7.13
AKE.PA Price Earnings VS Forward Price EarningsAKE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AKE is valued cheaper than 90.91% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, AKE is valued a bit cheaper than 77.27% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.81
EV/EBITDA 4.98
AKE.PA Per share dataAKE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)88.22
EPS Next 2Y5.68%
EPS Next 3Y6.35%

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.40%, AKE is a good candidate for dividend investing.
AKE's Dividend Yield is rather good when compared to the industry average which is at 3.03. AKE pays more dividend than 90.91% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, AKE pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.4%

5.2 History

The dividend of AKE is nicely growing with an annual growth rate of 6.86%!
Dividend Growth(5Y)6.86%
Div Incr Years3
Div Non Decr Years3
AKE.PA Yearly Dividends per shareAKE.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

77.22% of the earnings are spent on dividend by AKE. This is not a sustainable payout ratio.
The dividend of AKE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP77.22%
EPS Next 2Y5.68%
EPS Next 3Y6.35%
AKE.PA Yearly Income VS Free CF VS DividendAKE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
AKE.PA Dividend Payout.AKE.PA Dividend Payout, showing the Payout Ratio.AKE.PA Dividend Payout.PayoutRetained Earnings

ARKEMA

EPA:AKE (5/23/2025, 7:00:00 PM)

65.35

-1.3 (-1.95%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)07-31 2025-07-31
Inst Owners52.1%
Inst Owner ChangeN/A
Ins Owners0.54%
Ins Owner ChangeN/A
Market Cap4.97B
Analysts78.26
Price Target96.96 (48.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.4%
Yearly Dividend3.47
Dividend Growth(5Y)6.86%
DP77.22%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-10.09%
Min EPS beat(2)-18.44%
Max EPS beat(2)-1.73%
EPS beat(4)2
Avg EPS beat(4)-0.7%
Min EPS beat(4)-18.44%
Max EPS beat(4)8.93%
EPS beat(8)5
Avg EPS beat(8)1.72%
EPS beat(12)9
Avg EPS beat(12)9.54%
EPS beat(16)13
Avg EPS beat(16)15.47%
Revenue beat(2)0
Avg Revenue beat(2)-1.57%
Min Revenue beat(2)-2.56%
Max Revenue beat(2)-0.57%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)3.26%
Revenue beat(8)2
Avg Revenue beat(8)-1.34%
Revenue beat(12)6
Avg Revenue beat(12)0.07%
Revenue beat(16)10
Avg Revenue beat(16)1.27%
PT rev (1m)-7.77%
PT rev (3m)-9.95%
EPS NQ rev (1m)1.74%
EPS NQ rev (3m)-29.84%
EPS NY rev (1m)0%
EPS NY rev (3m)-16.28%
Revenue NQ rev (1m)-0.5%
Revenue NQ rev (3m)-4.22%
Revenue NY rev (1m)-3.22%
Revenue NY rev (3m)-3.34%
Valuation
Industry RankSector Rank
PE 8.62
Fwd PE 7.13
P/S 0.52
P/FCF 13.81
P/OCF 4.43
P/B 0.66
P/tB 2.39
EV/EBITDA 4.98
EPS(TTM)7.58
EY11.6%
EPS(NY)9.17
Fwd EY14.03%
FCF(TTM)4.73
FCFY7.24%
OCF(TTM)14.74
OCFY22.55%
SpS125.48
BVpS98.95
TBVpS27.37
PEG (NY)N/A
PEG (5Y)88.22
Profitability
Industry RankSector Rank
ROA 2.22%
ROE 4.49%
ROCE 5.64%
ROIC 3.98%
ROICexc 4.74%
ROICexgc 9.65%
OM 7.52%
PM (TTM) 3.54%
GM 20.32%
FCFM 3.77%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexcg growth 3Y-19.33%
ROICexcg growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 12.65
Debt/EBITDA 2.42
Cap/Depr 94.89%
Cap/Sales 7.97%
Interest Coverage 44.88
Cash Conversion 73.75%
Profit Quality 106.51%
Current Ratio 2.01
Quick Ratio 1.47
Altman-Z 1.8
F-Score4
WACC5.15%
ROIC/WACC0.77
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-9.91%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-34.43%
EPS Next Y-2.71%
EPS Next 2Y5.68%
EPS Next 3Y6.35%
EPS Next 5Y8.55%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-5.78%
Revenue Next Year1.65%
Revenue Next 2Y2.89%
Revenue Next 3Y3.26%
Revenue Next 5Y4.13%
EBIT growth 1Y-11.47%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year79.11%
EBIT Next 3Y27.21%
EBIT Next 5Y17.14%
FCF growth 1Y-39.39%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-11.87%
OCF growth 3Y7%
OCF growth 5Y-2.92%